Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen/Caffeine FDC in Post-Surgical Dental Pain
NCT02863575Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen, caffeine in odontalgia, sponsored by Pfizer. Started Oct 2017; status: completed.
02
Drugs
ibuprofencaffeine
03
Conditions
odontalgia
Beyond the preview
Go deeper on NCT02863575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02863575.